TOKYO--(BUSINESS WIRE)--Flatiron Health, and Lifebit Biotech Ltd (UK, London; hereafter “Lifebit”), are expanding their collaboration into Japan to transform cancer care, facilitating ground breaking research by allowing for safe and secure access to real-world data (RWD).

。

Building on the success of their multi-year strategic partnership, Lifebit’s pioneering federated Trusted Research Environment (TRE) technology will enable safe and secure access to Flatiron Health’s high-quality oncology RWD. Researchers with approved access to this RWD are able to safely utilize such data to power vital research, without removing data from the TRE.

在多年战略伙伴关系取得成功的基础上，Lifebit开创性的联合可信研究环境（TRE）技术将能够安全可靠地访问Flatiron Health的高质量肿瘤学RWD。获得批准访问此RWD的研究人员能够安全地利用此类数据为重要研究提供动力，而无需从TRE中删除数据。

Flatiron Health’s EHR-derived high quality RWD available in Japan —specifically the Japan gastric cancer, colorectal cancer and breast cancer datasets—have been securely accessed and are starting to be used for oncology research via Flatiron’s TRE, powered by Lifebit’s technology..

。。

“This collaboration will enable the secure provision of sensitive oncology RWD, and significantly enhance treatment and quality of life for cancer patients,” said Eri Tajima, Head of Strategic Partnerships at Flatiron Health Japan. “By integrating Lifebit’s advanced Trusted Research Environment technology with our commitment to revolutionizing cancer research and care, we aim to unlock the full potential of cancer data.

Flatiron Health Japan战略合作伙伴关系负责人Eri Tajima表示：“这种合作将确保敏感肿瘤学RWD的安全提供，并显着提高癌症患者的治疗和生活质量。”。“通过将Lifebit先进的可信研究环境技术与我们对彻底改变癌症研究和护理的承诺相结合，我们的目标是释放癌症数据的全部潜力。

This will accelerate research into new therapies and expedite the delivery of better treatments to patients.”.

这将加速对新疗法的研究，并加速为患者提供更好的治疗。”。

Lifebit’s TRE technology provides Flatiron Health with a highly secure and controlled computing environment that is designed to protect the privacy and security of sensitive data. It supports the most stringent levels of data governance by removing the need for data to be moved. Data instead remains in Flatiron’s secure environment and is analyzed in situ by authorized researchers..

Lifebit的TRE技术为Flatiron Health提供了一个高度安全和受控的计算环境，旨在保护敏感数据的隐私和安全。它不需要移动数据，从而支持最严格的数据管理级别。相反，数据保留在Flatiron的安全环境中，并由授权研究人员进行原位分析。。

'Our federated Trusted Research Environment allows for unparalleled access to valuable real-world cancer data, with the highest level of data security and privacy,' said Dr. Maria Dunford, CEO of Lifebit. 'We are excited to see the outcomes of this partnership, particularly in how it will contribute to improving cancer care and outcomes for patients worldwide.'.

Lifebit首席执行官玛丽亚·邓福德（MariaDunford）博士说：“我们的联邦可信研究环境可以无与伦比地访问有价值的现实世界癌症数据，并具有最高水平的数据安全性和隐私。我们很高兴看到这一伙伴关系的成果，特别是它将如何为改善全球患者的癌症护理和结果做出贡献。”。

In addition to protecting data privacy, TREs are a solution to advancing health research and insights through connection to large-scale, diverse and distributed data that are stored in separate locations across the world. Studying larger samples of diverse health data is known to increase findings and speed up scientific discoveries, leading to a greater understanding of how to detect, prevent, and treat diseases such as cancer.

除了保护数据隐私之外，TREs是一种通过连接存储在世界各地不同位置的大规模，多样化和分布式数据来推进健康研究和见解的解决方案。众所周知，研究大量不同健康数据的样本可以增加发现并加速科学发现，从而更好地了解如何检测，预防和治疗癌症等疾病。

Further, Flatiron’s TREs offer the ability to pool Flatiron RWD from different regions, allowing for further exploration of the transportability of evidence across markets..

此外，Flatiron的TRE能够汇集来自不同地区的Flatiron RWD，从而进一步探索跨市场证据的可运输性。。

Flatiron Health operates internationally in the US, the United Kingdom, Germany, and Japan. The company collaborates with hospitals and health networks in each of these countries and regions to develop customized strategies, aiming to transform and harness the potential of RWD.

Flatiron Health在美国、英国、德国和日本开展国际业务。该公司与这些国家和地区的医院和卫生网络合作，制定定制战略，旨在转变和利用RWD的潜力。

Lifebit’s federated TRE technology delivers this necessary security and is already in use with major initiatives including Genomics England, the UK government’s flagship genomics health and research endeavor, Synapxe, Singapore’s national HealthTech agency, and CanPath (the Canadian Partnership for Tomorrow’s Health), Canada’s largest population health study..

Lifebit的联合TRE技术提供了这种必要的安全性，并已用于重大举措，包括英国政府旗舰基因组健康与研究机构Genomics England，新加坡国家健康技术机构Synapxe和加拿大最大的人口健康研究机构CanPath（加拿大明天健康伙伴关系）。。

Scientific Impact of Flatiron Health Japan RWD and Lifebit TRE Technology

扁平铁健康日本RWD和Lifebit TRE技术的科学影响

Flatiron Health will be presenting findings from original research on early-onset gastric and colorectal cancer in Japan and the U.S. at the Asian Conference of Pharmacoepidemiology (ACPE) hosted in Tokyo, from October 12-14 2024.

Flatiron Health将于2024年10月12日至14日在东京举行的亚洲药物流行病学会议（ACPE）上介绍日本和美国早发性胃癌和结直肠癌原始研究的结果。

This study utilized de-identified electronic health record-derived Flatiron Health datasets from the U.S. and Japan. These research-ready datasets, processed and harmonized against a standardized data model, were pooled for analysis using Lifebit’s TRE technology, unlocking the potential for cross-country comparisons of patient cohorts..

这项研究利用了来自美国和日本的去识别电子健康记录衍生的扁钢健康数据集。这些研究就绪的数据集，根据标准化的数据模型进行处理和协调，汇集在一起，使用Lifebit的TRE技术进行分析，从而释放了对患者队列进行跨国比较的潜力。。

This study sets a precedent for further impactful evidence generation across markets, potentially increasing our understanding of differences in natural history by region and gaps in the standard of care between markets to inform future decision-making for improving patients’ access to care.

这项研究为跨市场进一步产生有影响力的证据奠定了先例，有可能增加我们对不同地区自然史差异的理解以及市场之间护理标准的差距，为未来改善患者获得护理的决策提供信息。

About Flatiron Health

关于扁钢健康

Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem.

Flatiron Health是一家healthtech公司，它扩大了肿瘤学护理点解决方案的可能性，并利用数据为每个癌症患者提供更智能的护理。通过机器学习和人工智能，现实世界的证据以及临床试验的突破，我们继续将患者的现实生活经验转化为知识，并创建一个更现代，相互关联的肿瘤学生态系统。

Flatiron Health is an independent affiliate of the Roche Group. @FlatironHealth.

Flatiron Health是罗氏集团的独立附属公司@扁平铁健康。

Flatiron Health, Inc. website: https://flatiron.com/

Flatiron Health, Inc. website: https://flatiron.com/

Flatiron Health K.K. website: https://flatiron.co.jp/

Flatiron Health K.K.网站：https://flatiron.co.jp/

About Lifebit

关于Lifebit

Lifebit is a global leader in genomics and health data and software, empowering organisations across the world to transform how they securely and safely leverage sensitive biomedical data. We are committed to solving the most challenging problems in precision medicine, genomics and healthcare with a mission to create a world where access to biomedical data will never again be an obstacle to curing diseases.

Lifebit是基因组学、健康数据和软件领域的全球领导者，它使世界各地的组织能够改变如何安全、安全地利用敏感的生物医学数据。我们致力于解决精准医学、基因组学和医疗保健领域最具挑战性的问题，其使命是创造一个生物医学数据不再成为治愈疾病的障碍的世界。

www.lifebit.ai @lifebitAI.

www.lifebit.ai @lifebitAI.